EOG
47
-2
DHR
47
3
NAVI
41
-5
ALL
56
3
ECL
47
2
ORCL
71
3
NWL
41
-3
MDLZ
38
-6
ADP
79
2
HPE
57
-12
ESS
36
2
EBAY
56
2
FAST
57
2
ADM
44
8
WYNN
46
-2
CMA
64
2
KMB
48
12
XRAY
38
-3
WMT
68
4
CHRW
73
2
EOG
47
-2
DHR
47
3
NAVI
41
-5
ALL
56
3
ECL
47
2
ORCL
71
3
NWL
41
-3
MDLZ
38
-6
ADP
79
2
HPE
57
-12
ESS
36
2
EBAY
56
2
FAST
57
2
ADM
44
8
WYNN
46
-2
CMA
64
2
KMB
48
12
XRAY
38
-3
WMT
68
4
CHRW
73
2
Financhill
Back

Harmony Biosciences Holdings 10K Form

Buy
96

HRMY
Harmony Biosciences Holdings

Last Price:
$35.06
Seasonality Move:
12.88%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HRMY News And Ratings

See the #1 stock for the next 7 days that we like better than HRMY

HRMY Financial Statistics

Sales & Book Value

Annual Sales: $714.7M
Cash Flow: $33.9M
Price / Cash Flow: 9.2
Annual Sales: $12.55
Price / Book: 2.8

Profitability

EPS (TTM): 2.62000
Net Income (TTM): $152.7M
Gross Margin: $557.9M
Return on Equity: 25.2%
Return on Assets: 16.29%

Harmony Biosciences Holdings Earnings Forecast

Key Harmony Biosciences Holdings Financial Ratios

  • The Gross Profit Margin over the past 7 years for HRMY is 78.06%.
  • The Selling, General & Administrative Expenses for HRMY have been equal to 30.96% of Gross Profit Margin.
  • The Research & Development expenses have been 20.40% of Revenue.
  • The Interest Expense is 12.03% of Operating Income.
  • The Net Earning history of HRMY is 20.36% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 4 years.

Harmony Biosciences Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: HRMY
Website: harmonybiosciences.com

Debt

Debt-to-Equity Ratio: 0.24
Current Ratio: 3.67
Quick Ratio: 3.5

Price-to-Earnings

Trailing P/E Ratio: 13.97
Forward P/E Ratio: 6.47

HRMY Technical Analysis vs Fundamental Analysis

Buy
96
Harmony Biosciences Holdings (HRMY) is a Buy

Is Harmony Biosciences Holdings a Buy or a Sell?